Salmonella enterica serovar Typhi (S. Typhi) is the etiological agent of typhoid fever, a major global health problem 1,2 . An assortment of evidence indicates that typhoid toxin is responsible for some of the more severe symptoms of typhoid fever [3][4][5] Given the observed plasticity in toxin assembly, we were intrigued by the observation that S. Typhi encodes a genomic islet containing a locus with significant sequence similarity to a pertussis-like toxin (Fig. 1a , Extended Data Fig. 1 ). However, although the gene for the delivery B subunit (sty1364) appears to encode a full-length protein, the gene encoding the active A subunit (sty1362) contains several stop codons and a ~200 bp C-terminal deletion, indicating that it is a pseudogene no longer encoding a functional protein. Therefore, sty1364, a pltB homolog, appears to encode an orphan B subunit, which we hypothesized may associate with PltA and CdtB to produce an alternative form of typhoid toxin (Fig. 1a) . In testing this hypothesis, we found that sty1364 exhibited a similar pattern of expression to the genes encoding other components of typhoid toxin 3,7,8 in that, although undetectable under standard laboratory conditions, it was induced >100-fold following S. Typhi infection of cultured human epithelial cells (Fig. 1b) . Similarly, sty1364 expression was strongly induced in S. Typhi grown in TTIM, a growth medium that mimics some aspects of the intracellular environment and is permissive for typhoid toxin expression in vitro 8 (Fig. 1c) PltC. Although most AB 5 toxins employ a homopentameric B subunit 9 , pertussis toxin is comprised of heteropentameric B subunit assembled from different but structurally related components 10,11 . However, we did not detect PltB in samples affinity purified from a tag present in PltC, indicating that typhoid toxin does not exhibit a single heteromeric B subunit architecture but rather it is assembled in two alternative configurations with PltB or PltC as its homopentameric subunit ( Fig. 1d-f ). We also observed an increase in the amount of PltB that co-immunoprecipitated with CdtB in a ΔpltC strain compared to wild type, indicating that, in the absence of PltC, more PltB-containing toxin is assembled thus suggesting that the two delivery subunits compete for their association to the active subunits (Figs. 1e, 1f). Collectively, these data indicate that upon infection of human cells S. Typhi assembles two distinct typhoid toxins with the same enzymatic "A" subunits but distinct delivery platforms or "B" subunits ( Fig. 1a) .
. Importantly, Sty1364 did not interact with CdtB in the absence of PltA, indicating that similar to the holotoxin assembled with PltB, Sty1364 forms a complex with CdtB only through its interaction with PltA (Figs 1d, 1e) . Sty1364 therefore appears to represent a bona fide typhoid toxin component and thus we have renamed it PltC. Although most AB 5 toxins employ a homopentameric B subunit 9 , pertussis toxin is comprised of heteropentameric B subunit assembled from different but structurally related components 10, 11 . However, we did not detect PltB in samples affinity purified from a tag present in PltC, indicating that typhoid toxin does not exhibit a single heteromeric B subunit architecture but rather it is assembled in two alternative configurations with PltB or PltC as its homopentameric subunit ( Fig. 1d-f ). We also observed an increase in the amount of PltB that co-immunoprecipitated with CdtB in a ΔpltC strain compared to wild type, indicating that, in the absence of PltC, more PltB-containing toxin is assembled thus suggesting that the two delivery subunits compete for their association to the active subunits (Figs. 1e, 1f) . Collectively, these data indicate that upon infection of human cells S. Typhi assembles two distinct typhoid toxins with the same enzymatic "A" subunits but distinct delivery platforms or "B" subunits ( Fig. 1a) .
To assess the function of the typhoid toxin assembled with PltC we examined the ability of the purified toxin to intoxicate cultured cells as measured by cell cycle arrest at G2/M due to the DNA damage inflicted by the CdtB subunit (Figs. 2a, 2b) 3, 7, 12 . We found that PltC-typhoid toxin was able to intoxicate cultured epithelial cells in a similar fashion to the PltB version of the toxin although with a higher (~7 fold) EC50. Interestingly, however, cultured cells infected with a strain that lacks pltC (exclusively producing PltBtyphoid toxin) were intoxicated in a manner indistinguishable to cells infected with wild type S. Typhi, although cells infected with a ∆pltB mutant strain (exclusively producing PltC-typhoid toxin) did not exhibit detectable signs of intoxication (Fig. 2c ). The observations that PltC-typhoid toxin is produced to significant levels during infection (Fig. 1e ) and is able to intoxicate when directly applied to cultured cells, but it does not intoxicate during bacterial infection suggested that the two alternative forms of the toxin might differ in their delivery mechanisms after their synthesis by intracellular S. Typhi.
We have previously shown that following its production, typhoid toxin is secreted from the bacterial periplasm into the lumen of the Salmonella-containing vacuole (SCV) by a specialized protein secretion mechanism involving a specialized muramidase that enables the toxin to cross to the trans side of the PG layer, from where it can be released by various membrane-active agonists such as bile salts or anti-microbial peptides 13 . We found that both forms of typhoid toxin are released from the bacteria using this same mechanism (Extended Data Fig. 2 ). It has been shown that after its secretion into the lumen of the SCV, typhoid toxin is packaged into vesicle transport intermediates that carry the toxin to the extracellular space, a process that is orchestrated by interactions of its B subunit PltB with specific luminal receptors 3,14 .
Therefore we examined whether differences in receptor specificity between PltB and
PltC may lead to differences in their intracellular transport pathways after bacterial infection. We infected cultured cells with wild-type S. Typhi or isogenic mutants carrying deletions in pltC, pltB, or both, and monitored the formation of CdtB-containing transport carriers using an immunofluorescence assay (Figs. 2d, 2e) . We found that toxin carriers were absent in cells infected with the ΔpltB strain although they were readily detected in cells infected with the ∆pltC mutant. These results indicate that the formation of the transport carriers is strictly dependent on PltB, presumably because the PltC version of typhoid toxin does not engage the sorting receptor. In fact, the level of transport carriers was measurably increased in cells infected with the ∆pltC S. Typhi mutant, an indication that the absence of PltC leads to the assembly of higher levels of export-competent PltBcontaining typhoid toxin. Collectively, these data indicate that the two typhoid toxins differ significantly with respect to their ability to engage the sorting receptors within the lumen of the SCV leading to substantial differences in the export of the toxins to the extracellular space, a pre-requisite for intoxication after bacterial infection of cultured cells. These results also suggest that, during infection, the two toxins may exert their function in different environments and may target different cells.
To gain insight into potential differences between the activities of the two forms of typhoid toxin, we evaluated the consequences of systemically administering to C57BL/6 mice highly purified preparations of PltB-or PltC-typhoid toxins. We found that, although administering 2 µg of PltB-typhoid toxin was sufficient to kill all mice tested within five days, all mice administered 10 µg of PltC-Typhoid toxin (~5-fold more), survived for at least 10 days and the majority survived the full course of the experiment (Fig. 2f ).
Furthermore, in contrast to PltB-typhoid toxin 15 , mice receiving the PltC-typhoid toxin showed no neurological symptoms, but did lose weight and showed signs of malaise and lethargy, although these symptoms were delayed and less severe than those observed in the PltB-typhoid toxin treated animals ( Fig. 2g) . Peak toxicity for PltC-typhoid toxin treated mice was observed ~8-13 days post-administration, after which the majority of treated animals fully recovered. Interestingly, despite eliciting fewer and milder overt symptoms compared the PltB-typhoid toxin treated mice, PltC-typhoid toxin caused a significantly greater reduction in the numbers of total white blood cells, lymphocytes and monocytes ( Figure 2h ). Collectively, these data indicate that the two typhoid toxins preferentially target different cells/tissues. Therefore producing two toxins variants confers functional versatility to typhoid toxin, presumably enabling S. Typhi to expand the spectrum of host cell targets that it can engage.
Given the substantially different functional properties exhibited by the two forms of typhoid toxin, we reasoned that S. Typhi might have evolved regulatory mechanisms to preferentially produce the different forms of the toxin under different conditions. 
Methods

Bacterial Strains and Cell lines
S. Typhi strains employed in this study were derived from the wild-type isolate ISP2825 29 and were constructed using standard recombinant DNA and allelic exchange procedures using the E. coli β-2163 ∆nic35 as the conjugative donor strain 30 . Strains were routinely cultured in LB broth at 37 o C. For in vitro growth assays that employed typhoid toxin inducing growth conditions (TTIM) a previously described chemically defined growth medium was used 8 that was based on N minimal medium 31 . All experiments using cultured cells were conducted using the Henle-407 human epithelial cell line, which was obtained from the Roy Curtiss library collection. Cells were cultured in Dulbecco's modified Eagle medium (DMEM, GIBCO)
supplemented with 10% Fetal Bovine Serum (FBS) at 37 o C with 5% CO 2 in a humidified incubator. This cell line was routinely tested for mycoplasma contamination using a Mycoplasma Detection Kit (SouthernBiotech, Cat# 13100-01).
Salmonella Typhi infections
To infect Henle-407 cells, overnight cultures of S. Typhi were diluted 1/20 into fresh LB containing 0.3 M NaCl and grown to an OD 600 of 0.9. Cells were infected for 1 hour in Hank's balanced salt solution (HBSS) at the indicated multiplicity of infection (MOI). Cells were then washed three times with HBSS and incubated in culture medium containing 100 µg/ml gentamycin to kill extracellular bacteria. After 1 hour, cells were washed and fresh medium was added containing 5 µg/ml gentamycin to avoid repeated cycles of reinfection.
β-galactosidase assays
For in vitro grown samples, overnight cultures were washed two times with TTIM, diluted 1/20 into fresh TTIM and grown for the indicated amount of time at 37 o C at which point 10 or 20 µl of the culture was added to 90 µl of permeabilization buffer (100 mM Na 2 HPO 4 , 20 mM KCl, 2 mM MgSO 4 , 0.8 mg/ml hexadecyltrimethylammonium bromide [CTAB], 0.4 mg/ml sodium deoxycholate, 5.4 µL/ml β-mercaptoethanol) and assayed as described below. For samples collected from infected cells, 3x10 5 Henle-407 cells were plated in 6-well plates and grown for 24 hours prior to infection with the indicated strains. Following infections, cells were washed two times with PBS, released from the plates using dilute trypsin and pelleted by centrifugation for 5 minutes at 150 x g. Cells were then lysed in 0.1% sodium deoxycholate (in PBS) supplemented with 100 µg/ml DNase I and the lysate was centrifuged at 5,000 x g for 5 minutes to pellet the bacteria. The bacteria were re-suspended in PBS, a small aliquot of which was diluted to calculate the total number CFU recovered. The remainder of the bacteria were re-suspended in 100 µl of permeabilization buffer and assayed as described below. Assays were conducted at 24 hours post infection (hpi) unless otherwise indicated. β-galactosidase assays were conducted using a modified version of the protocol developed by Miller 32 8 . Briefly, samples were permeabilized for 20 minutes at room temperature in the buffer described above. 600 µl of substrate buffer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 2.7 µL/mL β-mercaptoethanol, 1 mg/ml ONPG [o-nitrophenyl-β-D-galactopyranoside, Sigma]) was then added to initiate the reactions.
Once the samples developed an obvious yellow colour, the reactions were quenched using 700 µl of 1M Na 2 CO 3 and the reaction time was noted. Cell debris was removed by centrifugation at 20,000 x g for 5 minutes and the OD 420 of the samples was measured. [culture]).
Co-immunoprecipitation experiments to identify interactions between toxin components
To identify interaction partners for the various typhoid toxin subunits, S. Typhi bacterial cell lysates were immunoprecipitated using C-terminal 3xFLAG epitope-tagged CdtB or PltC (tags were incorporated at the native genomic locus) as indicated and the eluates were analyzed by LC-MS/MS or western blot. A strain encoding a C-terminal 3xFLAG epitope-tagged version of MalE, a periplasmic protein that is expressed in TTIM, which was cloned in place of pltC at the pltC locus in the S. Typhi chromosome and included as a negative control for the LC-MS/MS analysis. For in vitro grown samples, the indicated strains were grown overnight in LB, washed twice using TTIM, diluted 1/20 into 12ml of fresh TTIM and grown overnight. Cultures were pelleted, re-suspended in lysis buffer (50 mM Tris pH 7.5, 170 mM NaCl, cOmplete mini protease inhibitors [Sigma] , 40 ug/ml DNase I) and lysed using the One Shot cell disruption system (Constant Systems, Ltd). Clarified lysates were immunoprecipitated overnight at 4 o C using ANTI-FLAG M2 affinity gel (Sigma). Immunoprecipitated samples were washed thoroughly using 50 mM Tris pH 7.5/170 mM NaCl/50 mM galactose/0.1% Triton X-100 and eluted using 0.1M glycine-HCl (LC-MS/MS) or SDS-PAGE loading buffer (western blot analysis). For LC-MS/MS analysis, the eluted samples were precipitated overnight at -20 o C in 80% acetone and washed twice using 80% acetone. The samples were then reduced using DTT, alkylated using iodoacetamide and trypsin digested overnight. C18 column purified peptides were then analyzed by LC/MS/MS as previously described 33 and MS/MS scans were processed and searched using MASCOT (Matrix Science Ltd.). The resulting peptide and protein assignments were filtered to keep only those identifications with scores above extensive homology. For western blot analysis, eluted samples were run on 15% SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked using 5% non-fat milk, incubated overnight at 4 o C with the indicated primary antibody followed by a 2 hour incubation with a fluorescently conjugated α-mouse (FLAG) or α-rabbit (PltB) secondary antibody and analyzed using the Li-Cor Odyssey blot imager.
For samples isolated from infected cells, three 15 cm dishes containing a total of 7.5x10 7
Henle-407 cells were infected at an MOI of 20 as described above using each of the indicated S. Typhi strains. 24 hours post-infection, cells were washed twice using PBS and collected using a cell scraper, pelleted and washed once using PBS. Cell pellets were then resuspended in lysis buffer (50 mM Tris pH 7.5, 170 mM NaCl, complete mini protease inhibitors [Sigma] , 40 ug/ml DNase I, 10 mM N-ethylmaleimide) and lysed using a Branson Digital Sonifier (3 seconds on/8 seconds off, 35% amplitude, 3 minutes total). Clarified lysates were then immunoprecipitated and analyzed by western blot as described above.
Typhoid toxin purification
Both typhoid toxins were purified according to a previously established protocol 15 .
Briefly, pltB, pltA and cdtB-6xHis (PltB-typhoid toxin) or pltC, pltA and cdtB-6xHis (PltC-typhoid toxin) were cloned into pET28a(+) vector (Novagen). E. coli strains carrying these expression vectors were grown to OD 600 ~ 0.8, at which time 250 µM IPTG was added to induce the expression of the toxin genes and the cultures were grown overnight at 30 o C. Bacterial cells were pelleted by centrifugation and lysed. Crude lysates were affinity purified using Nickel resin (Qiagen), followed by cation exchange chromatography using a Mono S column (Sigma-Aldrich) and finally gel filtration using a Superdex-200 column (Sigma-Aldrich). The final fractions were analyzed by SDS-PAGE to confirm purity.
Culture cell intoxication assays
To assess typhoid toxin toxicity in cultured human cells, the number of cells arrested in G2/M (as a consequence of CdtB-mediated DNA damage) was determined using flow cytometry as previously described 15 . For experiments using purified toxin, 2.5x10 4 Henle-407 epithelial cells were plated in 12-well plates. Twenty four hours later the cells were washed and fresh medium containing the indicated concentrations of PltB-or PltC-typhoid toxin were added.
Forty eight hours later, the cells were removed from the dishes using trypsin treatment, pelleted, re-suspended in 300 µl PBS, fixed by adding ice cold ethanol dropwise to a final concentration of 70% and incubated overnight at -20 o C. Cells were then washed with PBS, re-suspended in 500 µl of PBS containing 50 µg/ml propidium iodide, 0.1 µg/ml RNase A and 0.05% Triton X-100 and incubated for 30 minutes at 37 o C. Cells were then washed and re-suspend in PBS, filtered and analyzed by a flow cytometry. The DNA content of cells was determined using FlowJo (Treestar). In order to obtain EC 50 values, the percentage of cells in the G2/M phase (% G2/M) was determined for each sample and converted to normalized toxicity by subtracting the % G2-M value observed of untreated cells and diving by (maximum % G2/M -untreated % G2/M). The maximum % G2/M value was considered to be 90% based on our experience that values above this number are not reliably observed even at saturating toxin concentrations. For experiments using S. Typhi infected cells, 2.5x10 4 Henle-407 cells were plated in 12-well plates and were infected using the indicated S. Typhi strains at the indicated MOI values 24 hours later. Forty eight hours post-infection the cells were collected, fixed, stained and analyzed as described above.
Typhoid toxin secretion assay
To assess the mechanism of secretion for the PltB-and PltC typhoid toxins, an in vitro toxin secretion assay was employed to determine whether toxin secretion from ΔpltB (producing exclusively PltC-typhoid toxin) and ΔpltC (producing exclusively PltB-typhoid toxin) S. Typhi strains was dependent upon both TtsA and outer membrane perturbation, in accordance with the recently described mechanism of typhoid toxin secretion 13 . The indicated strains, all of which encode 3x-FLAG epitope-tagged cdtB from its native genomic locus, were grown overnight in LB, washed twice using TTIM, diluted 1/20 into fresh TTIM and grown for 24 hours at 37 o C to induce typhoid toxin and ttsA expression. The bacteria were then pelleted, washed thoroughly, and incubated for 15 minutes either in 0.075% bile salts (Sigma) in PBS or in PBS alone (mock treated). The bacteria were then pelleted and the supernatants were filtered using a 0.2 µm filter and TCA precipitated. The amount of toxin in the pellet and supernatant fractions was then determined by western blot analysis using an M2 α-FLAG antibody as described above.
Immunofluorescence microscopy assay for typhoid toxin export
To compare the export of typhoid toxin from the Salmonella-containing vacuole to the extracellular space for PltB-typhoid toxin and PltC-typhoid toxin, we employed a previously established immunofluorescence-based assay that quantifies the levels typhoid toxin that are within exocytic vesicles compared to the levels associated with bacteria 14 . Henle-407 cells plated on glass coverslips were infected with the indicated cdtB-3xFLAG epitope-tagged S.
Typhi strains at a moiety of infection of 10. Forty eight hours post-infection, the samples were fixed in 4% paraformaldehyde and blocked using 3% BSA/0.3% triton X-100 in PBS. The coverslips were then incubated with a 1:5,000 dilution of mouse monoclonal M2 anti-FLAG antibody (Sigma) and a 1:10,000 dilution of rabbit polyclonal anti-S. Typhi LPS antibody (Sifin) overnight at 4 o C. After thoroughly washing in PBS, samples were then stained using Alexa 488-conjugated anti-mouse and Alexa 594-conjugaed anti-rabbit antibodies and DAPI (Sigma) for 2 hours at room temperature, washed extensively using PBS, mounted on coverslips, and imaged imaged using an Eclipse TE2000 inverted microscope (Nikon) with an Andor Zyla 5.5 sCMOS camera driven by Micromanager software (https://www.micro-manager.org).
The open source software ImageJ (http://rsbweb.nih.gov/ij/) was used to quantify toxin export in images captured in random fields as described previously 14 . Briefly, the LPS signal was used to identify the bacterial cells and the CdtB-3xFLAG signal was used to identify typhoid toxin. The typhoid toxin signal within the area associated with bacterial cells was subtracted from the total typhoid toxin signal in order to obtain the signal associated with typhoid toxin carrier intermediates. In a given field, the fluorescence intensity of the typhoid toxin signal that was associated with toxin carriers was normalized to the bacterial-associated typhoid toxin signal within the same field.
Animal intoxication experiments
All animal experiments were conducted according to protocols approved by Yale University's Institutional Animal Care and Use Committee. C57BL/6 mice were anesthetized with 30% w/v isoflurane in propylene glycol and 100 µl of toxin solution containing the indicated concentration of purified PltB-or PltC-typhoid toxin was administered via the retro-orbital route.
Changes in behavior, weight and survival of the toxin-injected mice were closely monitored for the duration of the experiment. Blood samples were collected by cardiac puncture 4 days after toxin administration in Microtainer tubes coated with EDTA, kept at room temperature and analyzed within 2 hours after blood collection using a HESKA Veterinary Hematology System.
FAST-INSeq screen
The FAST-INSeq screen was employed to identify S. Typhi genes that, when disrupted by transposon mutagenesis, lead to altered expression of a pltC:gfp reporter within infected Henle-407 epithelial cells. This screen was conducted as previously described 8 using a pltB:gfp reporter. Transposon mutagenesis was conducted using a mariner transposon delivered by pSB4807, which was mobilized into the pltC:gfp S. Typhi strain by conjugation using E. coli β-2163 ∆nic35 as the donor strain. Mutants were selected by plating on LB agar plates containing 30 µg/ml chloramphenicol. A total of ~150,000 mutants were collected and multiple aliquots of this library were stocked for subsequent use in the screen. For each iteration of the screen, five 15 cm dishes were seeded with 1x10 7 Henle-407 cells each and grown for ~24 hours prior to infection using the transposon mutant library described above. Aliquots of the inoculum used for infection were collected for subsequent INSeq preparation (inoculum pool). 18 hours post infection, the cells were washed three times with PBS, detached from plates using dilute trypsin and pelleted by centrifugation at 150 x g for 5 minutes. Cells were lysed using a 5 min incubation in 0.1% sodium deoxycholate (in PBS) supplemented with 100 µg/ml DNase I to degrade and solubilize the genomic DNA released from lysed host cells. The lysate was centrifuged at 5,000 x g for 5 minutes to isolate S. Typhi from the soluble cellular debris. The S.
Typhi-containing pellet was re-suspended in PBS and further purified from cellular debris using two spins at 150 x g for 5 minutes (discarding the pellet fraction) and one spin at 5,000 x g for 5 minutes (discarding the supernatant). An aliquot of the recovered S. Typhi was amplified by growth in LB at 37 o C and subsequently prepared for INSeq sequencing (post-infection pool) and the remainder was washed and diluted in PBS to a concentration of ~2x10 6 bacteria/ml for FACS. A total of ~2x10 7 S. Typhi mutants were sorted according to their fluorescence intensity in the GFP channel (488 nm excitation, 515/20 with 505LP emission) using a BD FACS Aria II flow cytometer. The isolated low fluorescence and high fluorescence pools were amplified by growth in LB at 37 o C and subsequently prepared for INSeq sequencing. The screen was conducted using the same mutant library on two independent occasions, and the low fluorescence pools from these two sorts were pooled and re-sorted (re-sort of low fluorescence populations).
For INSeq sequencing, genomic DNA was extracted from each of the mutant pools, digested with MmeI (New England Biolabs) and barcoded samples were prepared for sequencing as described previously 34 . The purified 121 bp DNA products containing barcodes to identify the individual mutant pools were sequenced on an Illumina HiSeq2000 system at the Yale Center for Genomic Analysis. The sequencing data were analyzed using the INSeq_pipeline_v3 package 35 , which separated sequencing reads by pool, mapped/quantified insertions and grouped insertions by gene. For each pool, the total number of sequencing reads was normalized to be 2,176,000 (an average of 500/gene). To identify genes in which insertions were enriched in a statistically significant manner in one pool compared to another, a value of 50 (10% of the average number of reads per gene) was added to the normalized number of reads in both pools. Ratios of the log-transformed read numbers for the two pools were then calculated. Genes with values that were an average of more than two standard deviations from the mean over the two primary replicates of the screen and more than one standard deviation from the mean in all three sorts were considered to be significantly enriched.
Analytical flow cytometry
To probe pltB and pltC expression within infected cells at the single bacterium level, we Fig. 2 . Both typhoid toxins are secreted using the same TtsA-dependent secretion mechanism. The mechanism of typhoid toxin secretion was recently described, in which the activity of the specialized muramidase TtsA enables the toxin to access the trans side of the peptidoglycan layer, after which it can be released following exposure to outer membrane perturbing agents such as bile salts 13 . To determine whether this mechanism is utilized by both PltC-typhoid toxin and PltB-typhoid toxin, an in vitro secretion assay was performed 13 . The indicated strains, all of which encode a 3xFLAG-epitope tagged CdtB, were grown for 24 hours in TTIM medium to induce typhoid toxin (and ttsA) expression, after which the bacteria were pelleted and washed thoroughly. The material was evenly divided between two samples, one of which was incubated in PBS containing 0.075% bile salts (B.S.) and the other in PBS only. Samples were then pelleted and the levels of CdtB-3xFLAG in the pellet fraction and in filtered culture supernatants (Sup.) were analyzed by western blot. Fig. 3 . Expression of pltC by intracellular S. Typhi, unlike the other typhoid toxin genes, does not require the PhoP/PhoQ two-component system. Henle-407 cells were infected using wild type and ΔphoP/phoQ mutant S. Typhi strains that encode 3xFLAG epitope-tagged versions of both cdtB and pltC at their native genomic loci, as well as an untagged control strain. Whole cell lysates from the inoculum used for the infections as well as the bacteria isolated from infected cells 24 hours post-infection were analyzed by western blot. Sample loading was normalized to CFU recovery and lysate from 2.5x10 7 bacteria was loaded in each lane. Table 1 ). To probe the role of these regulators in the expression of pltB and pltC, a flow cytometry analysis of pltB:gfp and pltC:gfp expression was conducted of the indicated S. Typhi strains 24 hours post-infection. Histograms show the GFP fluorescence intensities of individual bacteria. For both strains, the wild-type samples show high fluorescence (most bacteria) and low fluorescence (rare bacteria) populations; gates were established to show the percentage of bacteria in these populations for each strain, as well as those with an intermediate level of fluorescence ("int") and those with a level greater than 99.9% of the wild-type population (> high). The proportions of bacteria with fluorescence intensities within these gates is shown (bottom). The heterogeneous expression of pltC in the ΔphoP/phoQ and ΔenvZ/ompR strains is likely due to their influence over ssrA/ssrB expression 24 36 . Fig. 5 . Congruent phylogenetic distributions of the typhoid toxin islet and a second pertussis toxin-like B subunit homolog in the Salmonella genus. Depiction of different genomic arrangements of the typhoid toxin islet and of loci encoding a second putative B subunit that were identified by searching the NCBI genome database. All genomic locations are shown relative to the S. Typhi reference genome (black arrows). Large genomic islands absent from the Typhi genome are shown in yellow, pseudogenes are shown as grey boxes and ADP-ribosyltransferase (ADP-RT) pseudogenes have a red outline. The depicted genomic arrangements appear, based on the available sequence data, to be conserved across the cited species (Sp.), subspecies (Ssp.), clade, serovar (Sv.) or strains, as indicated. Fig. 6 . Examples of AB 5 -type toxins and orphan homologous delivery subunits encoded within the same genome outside the Salmonella genus. Using BLAST homology searches using AB 5 -type toxin subunits, genomes encoding an AB 5 -type toxin as well as a homologous orphan delivery subunit were identified and are depicted above. (a) In addition to the five-gene pertussis toxin locus 37 , we found that B. pertussis encodes two putative AB 5 toxin delivery subunits at a distant genomic locus that does not also encode a putative toxin active subunit, bp1251 and bp1252. Bp1251 is >30% identical to both PtxB and PtxC over >200 amino acids. Bp1252 was identified as a statistically significant hit (e value < 0.02) to PtxB, PtxC and PtxE using the HHPred protein homology detection tool (https://toolkit.tuebingen.mpg.de/#/tools/hhpred). (b) The putative AB 5 -type toxin Yersinia toxin 38 is encoded by ytxA and ytxB in Y. enterocolitica. At a distant genomic location, Y. enterocolitica also encodes an orphan pertussis toxin-like delivery subunit, ye1123A. YtxA and Ye1123A exhibit significant sequence similarity to the pertussis-like toxin ArtAB; YtxA is > 60% identical to ArtA and Ye1123A is ~30% identical to ArtB. 
Extended Data
Extended
Extended Data
